Project Scientific Publications
1. The PREGACT Study Group. Four Artemisinin-Based Treatments in African Pregnant Women with Malaria. N Engl J Med 2016; 374: 913-27. doi:10.1056/NEJMoa1508606
2. Desai M, Hill J, Fernandes S, Walker P, Pell C, Gutman J, et al.
Prevention of malaria in pregnancy. Lancet Infect Dis. 2018 Jan 30. doi: 10.1016/S1473-3099(18)30064- 1.
3. Rueangweerayut R, Phyo AP, Uthaisin C, Poravuth Y, Binh TQ, Tinto H, et al. Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. N Engl J Med. 2012 Apr 5;366(14):1298-309. doi:…
4. Tshefu AK, Gaye O, Kayentao K, Thompson R, Bhatt KM, Sesay SS, et al. Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children…
5. Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of…
6. Mens PF, Bojtor EC, Schallig HD. Molecular interactions in the placenta during malaria infection. Eur J Obstet Gynecol Reprod Biol. 2010 Oct;152(2):126-32. doi: 10.1016/j.ejogrb.2010.05.013.
7. Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, et al. A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether- lumefantrine…
8. Ismail MR, Ordi J, Menendez C, Ventura PJ, Aponte JJ, Kahigwa E, et al. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol. 2000 Jan;31(1):85-93. doi:…
9. WHO. Methods for surveillance of antimalarial drug efficacy. Geneva, Switzerland. 2009.
10. Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, et al. Review of pyronaridine anti-malarial properties and product characteristics. Malar J. 2012 Aug 09;11:270. doi: 10.1186/1745-6215-15-340.
11. D’Alessandro U. Existing antimalarial agents and malaria-treatment strategies. Expert Opin Pharmacother. 2009 Jun;10(8):1291-306. doi: 10.1517/14656560902942319.
12. Baiden R, Oduro A, Halidou T, Gyapong M, Sie A, Macete E, et al. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim(R) (dihydroartemisinin/piperaquine),…
13. Manyando C, Kayentao K, D’Alessandro U, Okafor HU, Juma E, Hamed K. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.…
14. Snappin S. Noninferiority trials. Curr Controll Trials in Cardiovasc Med 2000; 1:19- 21. 2000. DOI: 10.1186/cvm-1-1-019
15. CPMP. Committee for Proprietary Medicinal Products (CPMP) (2000) “Points to consider on switching between superiority and noninferiority” The European Agency for the Evaluation of Medicinal Products, London. 2000.
16. Mwesigwa J, Okebe J, Affara M, Di Tanna GL, Nwakanma D, Janha O, et al. On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide…
17. Gonzalez R, Munguambe K, Aponte J, Bavo C, Nhalungo D, Macete E, et al. High HIV prevalence in a southern semi-rural area of Mozambique: a community-based survey. HIV Med.…
18. Scott S, Mens PF, Tinto H, Nahum A, Ruizendaal E, Pagnoni F, et al. Community- based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant…
19. Coulibaly SO, Kayentao K, Taylor S, Guirou EA, Khairallah C, Guindo N, et al. Parasite clearance following treatment with sulphadoxine-pyrimethamine for intermittent preventive treatment in Burkina-Faso and Mali: 42-day…
20. Kayentao K, Doumbo OK, Penali LK, Offianan AT, Bhatt KM, Kimani J, et al. Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial. Malar…
21. Kayentao K, Guirou EA, Doumbo OK, Venkatesan M, Plowe CV, Parsons TL, et al. Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co- infection. Am J Trop…
22. Tagbor H, Cairns M, Bojang K, Coulibaly SO, Kayentao K, Williams J, et al. Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy. PLoS One. 2015;10(8):e0132247.…
23. Ceesay SJ, Casals-Pascual C, Nwakanma DC, Walther M, Gomez-Escobar N, Fulford AJ, et al. Continued decline of malaria in The Gambia with implications for elimination. PLoS One. 2010 Aug…
24. WHO. World malaria report 2017. http://wwwwhoint/malaria/publications/world- malaria-report-2017/en/. 2017.
25. Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA. Community permission for medical research in developing countries. Clin Infect Dis. 2005 Jul 15;41(2):255-9. doi: 10.1086/430707